Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Abstract 1956: miR-181d degradation mediated genetic heterogeneity and acquired resistance

Valya Ramakrishnan, Johnny Akers, Thien Nguyen, Aaron Wang, Bandita Adhikari, Brian Hirshman, Jie Li, Jann Sarkaria, Wei Hua, Mao Ying, Masayuki Nitta, Tao Jiang, Bob Carter, Clark C. Chen

Cancer Res (2018) 78 (13_Supplement): 1956.

https://doi.org/10.1158/1538-7445.AM2018-1956

Published: 01 July 2018

View article titled, Abstract 1956: miR-181d degradation mediated genetic heterogeneity and acquired resistance

Journal Articles

Abstract 979: Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression

Cancer Res (2015) 75 (15_Supplement): 979.

https://doi.org/10.1158/1538-7445.AM2015-979

Published: 01 August 2015

View article titled, Abstract 979: Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression

Journal Articles

Abstract PR13: Epigenetic regulation of MYC drives dynamic transition between tumor initiating states in glioblastoma

David Kozono, Jie Li, Masayuki Nitta, Oltea Sampetrean, Kimberly Ng, David Gonda, Deepa Kushwaha, Matsui Hiroko, Olivier Harismendy, Oren Becher, Chang-Hyuk Kwon, Keith L. Ligon, Hideyuki Saya, Bob S. Carter, Donald Pizzo, Scott Vandenberg, Clark C. Chen

Cancer Res (2015) 75 (1_Supplement): PR13.

https://doi.org/10.1158/1538-7445.CHTME14-PR13

Published: 12 January 2015

View article titled, Abstract PR13: Epigenetic regulation of MYC drives dynamic transition between tumor initiating states in glioblastoma

Journal Articles

Abstract 2737: Modulation of mitotic DNA damage as a paradigm for glioblastoma therapy

Ying Shen, Masayuki Nitta, Jie Li, Diahnn Futalan, Tyler Steed, Zack Taich, Jeffrey M. Treiber, Deanna Stevens, Mark A. Schroeder, Jann N. Sarkaria, Hong-Zhuan Chen, Tao Jiang, Bob S. Carter, Fumiko Esashi, Jill Wakosky, Frank Furnari, Webster K. Cavenee, Arshad Desai, Clark C. Chen

Cancer Res (2014) 74 (19_Supplement): 2737.

https://doi.org/10.1158/1538-7445.AM2014-2737

Published: 01 October 2014

View article titled, Abstract 2737: Modulation of mitotic DNA damage as a paradigm for glioblastoma therapy

Journal Articles

Abstract 5218: A c-Myc driven threshold model of tumor initiating in glioblastoma

David Kozono, Masayuki Nitta, Oltea Sampetrean, Kimberly Ng, Dmitry Merzon, Deepa Kushwaha, Kaya Zhu, Keith Ligon, Shan Zhu, Hediyuki Saya, Clark C. Chen

Cancer Res (2012) 72 (8_Supplement): 5218.

https://doi.org/10.1158/1538-7445.AM2012-5218

Published: 15 April 2012

View article titled, Abstract 5218: A c-Myc driven threshold model of tumor initiating in glioblastoma

Journal Articles

Abstract 3301: c-Myc modulates the dynamic transition between tumor initiating states in glioblastoma

David Kozono, Masayuki Nitta, Kimberly Ng, Pascal O. Zinn, Deepa Kushwaha, Debbie Koay, Dmitry Merzon, Kaya Zhu, Shan Zhu, Keith Ligon, Clark Chen

Cancer Res (2011) 71 (8_Supplement): 3301.

https://doi.org/10.1158/1538-7445.AM2011-3301

Published: 15 April 2011

View article titled, Abstract 3301: c-Myc modulates the dynamic transition between tumor initiating states in glioblastoma

Journal Articles

Abstract 1318: Proteasome and Fanconi Anemia/BRCA pathways as prognostic determinants of glioblastoma response to radiation and temozolomide: a proposed clinical trial

David Kozono, Kimberly Ng, Grace Hsieh, Dmitry Merzon, Masayuki Nitta, Pascal O. Zinn, Kris Kahle, Steven Elledge, Alan D'Andrea, Clark C. Chen

Cancer Res (2010) 70 (8_Supplement): 1318.

https://doi.org/10.1158/1538-7445.AM10-1318

Published: 15 April 2010

View article titled, Abstract 1318: Proteasome and Fanconi Anemia/BRCA pathways as prognostic determinants of glioblastoma response to radiation and temozolomide: a proposed clinical trial

Journal Articles

K858, a Novel Inhibitor of Mitotic Kinesin Eg5 and Antitumor Agent, Induces Cell Death in Cancer Cells

Ryuichiro Nakai, Shin-ichi Iida, Takeshi Takahashi, Tetsuya Tsujita, Seiho Okamoto, Chie Takada, Kazuhito Akasaka, Shunji Ichikawa, Hiroyuki Ishida, Hideaki Kusaka, Shiro Akinaga, Chikara Murakata, Shinobu Honda, Masayuki Nitta, Hideyuki Saya, Yoshinori Yamashita

Cancer Res (2009) 69 (9): 3901–3909.

https://doi.org/10.1158/0008-5472.CAN-08-4373

Published: 30 April 2009

View article titled, K858, a Novel Inhibitor of Mitotic Kinesin Eg5 and Antitumor Agent, Induces Cell Death in Cancer Cells

Includes: Multimedia, Supplementary data

Journal Articles

Proteasome inhibition sensitizes malignant glioma to Temozolomide and ionizing radiation

Clark Chen, Richard Kennedy, Lauren Hu, Santosh Kesari, Masayuki Nitta, Renee Wright, Andrew Kung, Alan D'Andrea

Cancer Res (2008) 68 (9_Supplement): 431.

Published: 01 May 2008

View article titled, Proteasome inhibition sensitizes malignant glioma to Temozolomide and ionizing radiation

Journal Articles

Discovery and characterization of new antitumor agents targeting mitotic kinesin Eg5

Ryuichiro Nakai, Takeshi Takahashi, Tetsuya Tsujita, Seiho Okamoto, Chie Takada, Kazuto Akasaka, Hiroyuki Ishida, Shin-Ichi Iida, Shinobu Honda, Masayuki Nitta, Hideyuki Saya, Hideaki Kusaka, Shiro Akinaga, Chikara Murakata, Yoshinori Yamashita

Cancer Res (2005) 65 (9_Supplement): 1391.

Published: 01 May 2005

View article titled, Discovery and characterization of new antitumor agents targeting mitotic kinesin Eg5

Journal Articles

Cytoplasmic sequestration of activated ERK by PEA-15 contributes to the antitumor effect of E1A in Ovarian Cancer

Chandra Bartholomeusz, Hiroaki Itamochi, Masayuki Nitta, Hideyuki Saya, Mark H. Ginsberg, Naoto T. Ueno

Cancer Res (2005) 65 (9_Supplement): 355.

Published: 01 May 2005

View article titled, Cytoplasmic sequestration of activated ERK by PEA-15 contributes to the antitumor effect of E1A in Ovarian Cancer

Journal Articles

New insight of the cell cycle action leading to antitumor activity for Eg5 inhibitor

Shin-Ichi Iida, Shinobu Honda, Masayuki Nitta, Ryuichiro Nakai, Takeshi Takahashi, Tetsuya Tsujita, Seiho Okamoto, Chie Takada, Kazuto Akasaka, Hiroyuki Ishida, Hideaki Kusaka, Shiro Akinaga, Yoshinori Yamashita, Hideyuki Saya

Cancer Res (2005) 65 (9_Supplement): 397–398.

Published: 01 May 2005

View article titled, New insight of the cell cycle action leading to antitumor activity for Eg5 inhibitor

Journal Articles

Spindle checkpoint function is required for mitotic catastrophe induced by DNA-damaging agents

Masayuki Nitta, Osamu Kobayashi, Tomotoshi Marumoto, E. Antonio Chiocca, Hideyuki Saya

Cancer Res (2004) 64 (7_Supplement): 911.

Published: 01 April 2004

View article titled, Spindle checkpoint function is required for mitotic catastrophe induced by DNA-damaging agents

Journal Articles

Dependence of paclitaxel sensitivity on functional spindle assembly checkpoint

Tamotsu Sudo, Masayuki Nitta, Hideyuki Saya, Naoto T. Ueno

Cancer Res (2004) 64 (7_Supplement): 1296–1297.

Published: 01 April 2004

View article titled, Dependence of paclitaxel sensitivity on functional spindle assembly checkpoint

Journal Articles

Dependence of Paclitaxel Sensitivity on a Functional Spindle Assembly Checkpoint

Tamotsu Sudo, Masayuki Nitta, Hideyuki Saya, Naoto T. Ueno

Cancer Res (2004) 64 (7): 2502–2508.

https://doi.org/10.1158/0008-5472.CAN-03-2013

Published: 01 April 2004

View article titled, Dependence of Paclitaxel Sensitivity on a Functional Spindle Assembly Checkpoint

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 1956: miR-181d degradation mediated genetic heterogeneity and acquired resistance

Abstract 979: Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression

Abstract PR13: Epigenetic regulation of MYC drives dynamic transition between tumor initiating states in glioblastoma

Abstract 2737: Modulation of mitotic DNA damage as a paradigm for glioblastoma therapy

Abstract 5218: A c-Myc driven threshold model of tumor initiating in glioblastoma

Abstract 3301: c-Myc modulates the dynamic transition between tumor initiating states in glioblastoma

Abstract 1318: Proteasome and Fanconi Anemia/BRCA pathways as prognostic determinants of glioblastoma response to radiation and temozolomide: a proposed clinical trial

K858, a Novel Inhibitor of Mitotic Kinesin Eg5 and Antitumor Agent, Induces Cell Death in Cancer Cells

Proteasome inhibition sensitizes malignant glioma to Temozolomide and ionizing radiation

Discovery and characterization of new antitumor agents targeting mitotic kinesin Eg5

Cytoplasmic sequestration of activated ERK by PEA-15 contributes to the antitumor effect of E1A in Ovarian Cancer

New insight of the cell cycle action leading to antitumor activity for Eg5 inhibitor

Spindle checkpoint function is required for mitotic catastrophe induced by DNA-damaging agents

Dependence of paclitaxel sensitivity on functional spindle assembly checkpoint

Dependence of Paclitaxel Sensitivity on a Functional Spindle Assembly Checkpoint

Email alerts

AACR Journals

Resources

AACR Journals
on Social Media

Update search

Email alerts

AACR Journals

Resources

AACR Journals on Social Media

This Feature Is Available To Subscribers Only

AACR Journals
on Social Media